Back to top

Regeneron’s POTS Study Wraps Up: What REGN7544 Could Mean for REGN Investors

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals has finished a mid stage study tes...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regeneron Pharmaceuticals, Inc. (REGN)